News and Announcements
Proteomics International Wins WA Industry and Export Award
- Published October 19, 2015 12:11PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th October 2015, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce it has been awarded the Health and Biotechnology Export Award at The Western Australian 2015 Industry and Export Awards.
The award was presented at a Gala Dinner on the 16th October, hosted by WA Premier Colin Barnett, and it recognised outstanding international success in medical, healthcare and biotechnology fields for its products, technology, equipment, or services.
PILL was delighted to receive the Healthcare and Biotechnology Award. It provides significant validation for the Company’s world-leading expertise and capabilities in area of proteomics, the industrial scale study of the structure and function of proteins.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
